HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of gastrin 17 on beta-catenin/Tcf-4 pathway in Colo320WT colon cancer cells.

AbstractAIM:
To explore the effect of gastrin 17 (G17) on beta-catenin/T cell factor-4 (Tcf-4) signaling in colonic cancer cell line Colo320WT.
METHODS:
The pCR3.1/GR plasmid, which expresses gastrin receptor, cholecystokinin-2 receptor (CCK-2R), was transfected into a colonic cancer cell line Colo320 by Lipofectamine (TM)2000 and the stably expressing CCK-2R clones were screened by G418. The expression levels of gastrin receptor in the Colo320 and the transfected Colo320WT cell line were assayed by RT-PCR. Colo320WT cells were treated with G17 in a time-dependent manner (0, 1, 6, 12, 24 and 48 h), then with L365,260 (Gastrin(17) receptor blocker) for 30 min, and with G17 again for 12 h or L365,260 for 12 h. Expression levels of beta-catenin in a TX-100 soluble fraction and TX-100 insoluble fraction of Colo320WT cells treated with G17 were detected by co-immuniprecipation and Western blot. Immunocytochemistry was used to examine the distribution of beta-catenin in CoLoWT320 cells. Expression levels of c-myc and cyclin D1 in Colo320WT cells treated with G17 were assayed by Western blot.
RESULTS:
Expression levels of beta-catenin in the TX-100 solution fraction decreased apparently in a time-dependent fashion and reached the highest level after G17 treatment for 12 h, while expression levels of beta-catenin in the TX-100 insoluble fraction were just on the contrary. Immunocytochemistry showed that beta-catenin was translocated from the cell membranes into the cytoplasm and nucleus under G17 treatment. Expression levels of c-myc and cyclin D1 in the G17-treated Colo320WT cells were markedly higher compared to the untreated Colo320WT cells. In addition, the aforementioned G17-stimulated responses were blocked by L365,260.
CONCLUSION:
Gastrin17 activates beta-catenin/Tcf-4 signaling in Colo320WT cells, thereby leading to over-expression of c-myc and cyclin D1.
AuthorsJun Cao, Jie-Ping Yu, Chao-Hong Liu, Lan Zhou, Hong-Gang Yu
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 12 Issue 46 Pg. 7482-7 (Dec 14 2006) ISSN: 1007-9327 [Print] United States
PMID17167838 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CTNNB1 protein, human
  • Cyclin D
  • Cyclins
  • DNA, Complementary
  • Gastrins
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
  • Receptor, Cholecystokinin B
  • Recombinant Proteins
  • TCF Transcription Factors
  • TCF7L2 protein, human
  • Transcription Factor 7-Like 2 Protein
  • beta Catenin
  • gastrin 17
Topics
  • Base Sequence
  • Cell Line, Tumor
  • Colonic Neoplasms (drug therapy, genetics, metabolism)
  • Cyclin D
  • Cyclins (metabolism)
  • DNA, Complementary (genetics)
  • Gastrins (pharmacology)
  • Humans
  • Proto-Oncogene Proteins c-myc (metabolism)
  • Receptor, Cholecystokinin B (genetics, metabolism)
  • Recombinant Proteins (genetics, metabolism)
  • TCF Transcription Factors (metabolism)
  • Transcription Factor 7-Like 2 Protein
  • Transfection
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: